AMM
The 2025 AMM Innovation Forum will convene the foremost mRNA leaders to explore breakthroughs and accelerate progress across the field. Held at the headquarters of New England Biolabs in Ipswich, MA — with a virtual option available — the forum will feature keynote speakers, expert panels, and presentations from cutting-edge companies and researchers. Together, we’ll spotlight the most promising innovations shaping the future of medicine.
Meeting Details:
June 16, 2025
New England Biolabs
240 County Road, Ipswich, MA 01938
The 2025 AMM Innovation Forum offers a unique opportunity to connect with leaders driving the next wave of mRNA breakthroughs. Attendees will gain insights into emerging therapeutics, advances in manufacturing and delivery, and the critical raw materials powering progress. From rare diseases to oncology, AI integration to enzyme development, this forum is your front-row seat to what’s next in mRNA science — and how we can bring it to patients faster.
Nobel Prize in Physiology & Medicine (1993), Chief Scientific Officer, New England Biolabs
Entrepreneur and Former Chief Scientific Officer, Moderna
AMM Board Chair, Chief Development Officer and Co-Founder, Replicate Bioscience
Sir Richard Roberts, Nobel Prize in Physiology & Medicine (1993), Chief Scientific Officer, New England Biolabs
Andy Geall, AMM Board Chair
Melissa Moore
Entrepreneur and Former Chief Scientific Officer, Moderna
Tours Available
Breton Hornblower, NEB
The Alliance for mRNA Medicines (AMM) is the leading global organization dedicated to advancing and advocating for mRNA and next-generation encoding RNA therapeutics and vaccines for the benefit of patients, public health, and society. Our mission is to propel the future of mRNA medicine, improve patients’ lives, and advance scientific knowledge by convening and empowering mRNA industry leaders, innovators, scientists, and other key stakeholders.